The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation

Lamivudine was safe and effective in blocking HBV replication in renal transplant patients without any apparent increase in the risk of graft failure for the 24-month period of

In the present study, the activation status of B cells from peripheral blood of healthy controls (N = 20) and patients with acute hepatitis B (AHB, N = 15) or chronic hepatitis

ETV, in comparison with LVD, resulted in a lower cost per patient reaching undetectable viral load, a lower cost per life- year saved and a lower cost per QALY gained, in both

We created the following health states in Markov model for HBeAg-positive patients: virologic response, virologic resistance, compensated cirrhosis, decompen- sated

Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine. Matsuda M, suzuki f, suzuki Y,

GCB: grupo dos camundongos que receberam diariamente tratamento com 1g de pomada de extrato bruto de Caladium bicolor; GAL: grupos dos camundongos que foram tratados com 1g da

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

The role autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon alpha and ribavirin combination